image
Real Estate - REIT - Healthcare Facilities - NYSE - US
$ 9.125
3.69 %
$ 610 M
Market Cap
912.5
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one GMRE stock under the worst case scenario is HIDDEN Compared to the current market price of 9.12 USD, Global Medical REIT Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one GMRE stock under the base case scenario is HIDDEN Compared to the current market price of 9.12 USD, Global Medical REIT Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one GMRE stock under the best case scenario is HIDDEN Compared to the current market price of 9.12 USD, Global Medical REIT Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
141 M REVENUE
2.66%
37.9 M OPERATING INCOME
-2.30%
20.6 M NET INCOME
3.08%
68.4 M OPERATING CASH FLOW
-10.58%
67.6 M INVESTING CASH FLOW
149.26%
-144 M FINANCING CASH FLOW
-230.40%
34.2 M REVENUE
-11.63%
26.5 M OPERATING INCOME
106.07%
3.2 M NET INCOME
288.89%
16.3 M OPERATING CASH FLOW
-13.87%
-25.5 M INVESTING CASH FLOW
-1215.45%
9.16 M FINANCING CASH FLOW
143.58%
Balance Sheet Global Medical REIT Inc.
image
Current Assets 67.6 M
Cash & Short-Term Investments 26.4 M
Receivables 33.5 M
Other Current Assets 7.69 M
Non-Current Assets 1.2 B
Long-Term Investments 0
PP&E 11 M
Other Non-Current Assets 1.19 B
Current Liabilities 30 M
Accounts Payable 12.8 M
Short-Term Debt 405 K
Other Current Liabilities 16.8 M
Non-Current Liabilities 632 M
Long-Term Debt 619 M
Other Non-Current Liabilities 13.4 M
EFFICIENCY
Earnings Waterfall Global Medical REIT Inc.
image
Revenue 141 M
Cost Of Revenue 86.2 M
Gross Profit 54.7 M
Operating Expenses 16.9 M
Operating Income 37.9 M
Other Expenses 17.3 M
Net Income 20.6 M
RATIOS
38.82% GROSS MARGIN
38.82%
26.92% OPERATING MARGIN
26.92%
14.63% NET MARGIN
14.63%
3.53% ROE
3.53%
1.63% ROA
1.63%
3.06% ROIC
3.06%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Global Medical REIT Inc.
image
Net Income 20.6 M
Depreciation & Amortization 59 M
Capital Expenditures -10 M
Stock-Based Compensation 4.24 M
Change in Working Capital -5.69 M
Others -13.8 M
Free Cash Flow 58.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Global Medical REIT Inc.
image
Wall Street analysts predict an average 1-year price target for GMRE of $11.8 , with forecasts ranging from a low of $11.8 to a high of $11.8 .
GMRE Lowest Price Target Wall Street Target
11.8 USD 28.77%
GMRE Average Price Target Wall Street Target
11.8 USD 28.77%
GMRE Highest Price Target Wall Street Target
11.8 USD 28.77%
4. DIVIDEND ANALYSIS
2.51% DIVIDEND YIELD
0.21 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Global Medical REIT Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 years ago
Jan 10, 2023
Sell 49 K USD
MOORE ROSCOE M JR
Director
- 5000
9.7913 USD
3 years ago
Mar 04, 2022
Bought 20 K USD
Cole Henry
director:
+ 1287
15.5396 USD
3 years ago
Mar 03, 2022
Bought 31.1 K USD
Busch Jeffrey
Chairman, President and CEO
+ 2000
15.55 USD
3 years ago
Aug 19, 2021
Bought 15 K USD
Busch Jeffrey
Chairman, President and CEO
+ 1000
15.01 USD
3 years ago
Mar 08, 2021
Bought 13.8 K USD
Busch Jeffrey
Chairman, President and CEO
+ 1000
13.81 USD
3 years ago
Mar 08, 2021
Bought 10.4 K USD
Busch Jeffrey
Chairman, President and CEO
+ 750
13.81 USD
4 years ago
Aug 12, 2020
Bought 26.6 K USD
Marston Ronald
Director
+ 2000
13.3 USD
4 years ago
Aug 07, 2020
Bought 134 K USD
Busch Jeffrey
Chairman, President and CEO
+ 10000
13.39 USD
4 years ago
Mar 12, 2020
Bought 20 K USD
Cole Henry
Director
+ 1840
10.8581 USD
5 years ago
Aug 27, 2019
Bought 16 K USD
Cole Henry
Director
+ 1485
10.8 USD
5 years ago
Aug 26, 2019
Bought 2.14 K USD
Marston Ronald
Director
+ 200
10.69 USD
5 years ago
Aug 26, 2019
Bought 16.1 K USD
Marston Ronald
Director
+ 1500
10.72 USD
5 years ago
Aug 26, 2019
Bought 13.9 K USD
Marston Ronald
Director
+ 1300
10.68 USD
5 years ago
Mar 18, 2019
Sell 9.76 K USD
MOORE ROSCOE M JR
Director
- 1000
9.76 USD
5 years ago
Mar 18, 2019
Sell 48.2 K USD
MOORE ROSCOE M JR
Director
- 4945
9.75 USD
6 years ago
Dec 14, 2018
Bought 10 M USD
Huang Yanping
10 percent owner
+ 1111111
9 USD
6 years ago
Dec 14, 2018
Bought 10 M USD
ZH USA, LLC
10 percent owner
+ 1111111
9 USD
6 years ago
Dec 14, 2018
Bought 10 M USD
Zhang Jing Guo
director, 10 percent owner:
+ 1111111
9 USD
6 years ago
Nov 08, 2018
Bought 20 K USD
Cole Henry
Director
+ 2120
9.42 USD
6 years ago
Oct 26, 2018
Sell 15.1 K USD
Cypher Matthew
Director
- 1675
9.02 USD
6 years ago
Jun 04, 2018
Bought 25.1 K USD
Marston Ronald
Director
+ 2830
8.86 USD
6 years ago
May 11, 2018
Bought 3.99 K USD
Cypher Matthew
Director
+ 475
8.41 USD
6 years ago
Mar 13, 2018
Bought 14.4 K USD
Busch Jeffrey
Chairman, President and CEO
+ 2000
7.2 USD
6 years ago
Mar 13, 2018
Bought 14.1 K USD
Busch Jeffrey
Chairman, President and CEO
+ 2000
7.06 USD
6 years ago
Mar 12, 2018
Bought 14.2 K USD
Busch Jeffrey
Chairman, President and CEO
+ 2000
7.12 USD
7 years ago
Nov 14, 2017
Bought 9.3 K USD
Cole Henry
Director
+ 1000
9.3 USD
7 years ago
Nov 14, 2017
Bought 11.1 K USD
Cypher Matthew
Director
+ 1200
9.26 USD
7 years ago
Nov 14, 2017
Bought 24.4 K USD
Busch Jeffrey
Chairman, President and CEO
+ 2630
9.29 USD
7 years ago
Jun 30, 2017
Bought 99.9 K USD
Busch Jeffrey
Chairman, President
+ 11100
9 USD
8 years ago
Jul 01, 2016
Bought 0 USD
Busch Jeffrey
Chairman, President
+ 14000
0 USD
8 years ago
Jul 01, 2016
Bought 90.1 K USD
Busch Jeffrey
Chairman, President
+ 9000
10.01 USD
8 years ago
Jul 01, 2016
Bought 15 M USD
ZH USA, LLC
10 percent owner
+ 1179019
12.748 USD
8 years ago
Jul 01, 2016
Bought 15 M USD
Zhang Jing Guo
director, 10 percent owner:
+ 1179019
12.748 USD
9 years ago
Mar 02, 2016
Bought 15 M USD
ZH USA, LLC
10 percent owner
+ 1176655
12.748 USD
10 years ago
Jul 17, 2014
Bought 2.93 M USD
ZH USA, LLC
10 percent owner
+ 230000
12.748 USD
9 years ago
Jan 25, 2016
Bought 0 USD
ZH USA, LLC
10 percent owner
+ 0
12.748 USD
9 years ago
Mar 02, 2016
Bought 0 USD
ZH USA, LLC
10 percent owner
+ 0
12.748 USD
9 years ago
Mar 02, 2016
Bought 15 M USD
Huang Yanping
director, 10 percent owner:
+ 1176655
12.748 USD
10 years ago
Jul 17, 2014
Bought 2.93 M USD
Huang Yanping
director, 10 percent owner:
+ 230000
12.748 USD
9 years ago
Jan 25, 2016
Bought 0 USD
Huang Yanping
director, 10 percent owner:
+ 0
12.748 USD
9 years ago
Mar 02, 2016
Bought 0 USD
Huang Yanping
director, 10 percent owner:
+ 0
12.748 USD
11 years ago
Dec 10, 2013
Bought 25.6 B USD
CHAN FAI
10 percent owner
+ 2000000
12820 USD
7. News
Global Medical REIT Inc. Announces Dates for 2024 Fourth Quarter and Year-End Earnings Release and Webcast BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. Announces Dates for 2024 Fourth Quarter and Year-End Earnings Release and Webcast. businesswire.com - 2 weeks ago
REITs To Avoid This Year I am very bullish on REITs. But I still recognize that this sector is full of landmines. I highlight REITs to avoid this year. seekingalpha.com - 3 weeks ago
Global Medical REIT: Undervalued With Strong Rent Coverage And Occupancy Global Medical REIT offers a quality portfolio of healthcare facilities with long-term, triple-net leases, benefiting from favorable demographic trends and a strong tenant base. GMRE's current discounted valuation presents a potential for strong returns and high income, with a 10.6% dividend yield. At a forward P/AFFO ratio of 9.9, well below its historical average, GMRE is a speculative 'buy' for income-focused investors willing to balance risk and reward. seekingalpha.com - 1 month ago
Global Medical REIT Reports Tax Treatment of 2024 Dividends BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that information regarding the federal income tax treatment of the dividends paid in 2024 on the Company's common and preferred stock has been posted to the Company's website, at the following link. h. businesswire.com - 1 month ago
Global Medical REIT: Attractive Valuation Despite Refinancing Headwinds Global Medical REIT primarily invests in outpatient medical facilities, with the company's largest markets being Texas, Florida, and Ohio. The REIT should generate marginally higher AFFO in 2025 thanks to rent indexation, fading impact from the Steward Health Care bankruptcy, and portfolio growth. The company's debt is 81% fixed-rate at 3.18%, but low average maturity implies rising interest costs will weigh on AFFO growth in 2025-2026. seekingalpha.com - 1 month ago
Global Medical REIT Announces Succession Plan BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Announces Succession Plan Chief Executive Officer Transition Expected in 2025. businesswire.com - 1 month ago
Dividend Cut Alert: 1 REIT And 1 BDC With Unsustainable Yields REITs and BDCs are solid asset classes through which to facilitate income-oriented strategies. However, investors have to be still careful of not assuming excessive risks that might lead to unexpected dividend cuts. In this article, I share two high-yielding picks, where, in my view, the chances are high for experiencing a dividend cut in the foreseeable future. seekingalpha.com - 2 months ago
Sell Alert: 3 REITs That Likely Will Cut Their Dividend In 2025 Most REITs are well-positioned to grow dividends. But there are exceptions. I highlight three REITs that are at high risk of cutting their dividend. seekingalpha.com - 2 months ago
Global Medical REIT Inc. Board Declares 2024 Fourth Quarter Common and Preferred Dividends BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors (“Board”) has declared the Company's 2024 fourth quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2024 fourth quarter cash divid. businesswire.com - 2 months ago
1 REIT To Sell And 1 REIT To Buy The REIT market is not perfectly efficient. Some REITs are overpriced. Others are undervalued. I highlight a great example of that. seekingalpha.com - 3 months ago
Capitalize On The Dip: Two Durable 9% Yields To Load Up Your Income Portfolio High-yield stocks can fall due to non-dividend sustainability reasons, presenting opportunities for income investors to lock in attractive yields. In this article, I have identified two picks, which now yield about 9.5%. The beauty of both of these picks is that their fundamentals are sound and the dividends could be deemed sustainable. seekingalpha.com - 3 months ago
Global Medical REIT: Cash Flow Tracking Lower Than 9.4% Dividend Yield Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Steward Health Care's bankruptcy led to a new lease with CHRISTUS Health. There are a few concerns here on this high yielder, and we go over why we think $10.00 will be the ceiling on this stock. seekingalpha.com - 3 months ago
8. Profile Summary

Global Medical REIT Inc. GMRE

image
COUNTRY US
INDUSTRY REIT - Healthcare Facilities
MARKET CAP $ 610 M
Dividend Yield 2.51%
Description Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Contact 2 Bethesda Metro Center, Bethesda, MD, 20814 https://www.globalmedicalreit.com
IPO Date June 30, 2016
Employees 26
Officers Mr. Jeffrey M. Busch J.D. Chairman, President & Chief Executive Officer Mr. Jamie A. Barber General Counsel & Corporate Secretary Mr. Stephen C. Swett Investor Relations Executive Mr. Robert J. Kiernan CPA Chief Financial Officer & Treasurer Ms. Danica C. Holley Chief Operating Officer Mr. Alfonzo Leon Chief Investment Officer